Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN(®)) Botulinum Toxin in Chronic Refractory Migraine

Refractory chronic migraine is a disabling disorder impacting quality of life. BOTOX(®) (Onabotulinumtoxin A) is approved as a prophylactic treatment of chronic migraine in patients unresponsive to at least three prior preventive treatments. The objective of this study was to determine the prophylac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ion, Ioana, Renard, Dimitri, Le Floch, Anne, De Verdal, Marie, Bouly, Stephane, Wacongne, Anne, Lozza, Alessandro, Castelnovo, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024863/
https://www.ncbi.nlm.nih.gov/pubmed/29857565
http://dx.doi.org/10.3390/toxins10060221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024863/
https://www.ncbi.nlm.nih.gov/pubmed/29857565
http://dx.doi.org/10.3390/toxins10060221

Ejemplares similares